Brian Daniel is a speaker during a panel relating to innovation and brand value. The session aims to explore whether brands are a better predictor of innovation, and how that can help you leverage the value of your portfolio.
For more information on the conference, click here.
Biosimilars: Economic Issues for IP Litigation
In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...